IMS – Empowering Product Development for CPG, Personal Care and Pharmaceutical Companies

The IMS division of Florida Suncare Testing, Inc. helps to drive the success of R&D teams around the world — by empowering their product development organizations to develop superior formulations and breakthrough raw material technologies, more rapidly and at lower cost. In essence, fast, predictive in vitro methods and measurement technologies drive the creation of breakthrough products and innovative raw material technologies.

We recognize that development of breakthrough CPG, Cosmetic, OTC drug, and Pharmaceutical formulations involves a series of intricate, highly-complex tasks, and we look forward to assisting you with exceptional testing substrates, novel in vitro methods and advanced instrumentation.

IMS Culture at Florida Skincare Testing

The IMS division focuses on synthetic skin technologies to empower new product development of our customers. We see ourselves as a resource, an extension of your organization. As an integral part of FSTI, the team has the expertise, passion and commitment to expand on the success enjoyed by IMS’s twenty years of excellence. Visit for a broader understanding of the company as a whole.

IMS History
Dr. John P. Sottery founded IMS in 1992 with the purpose of designing new technologies to empower global product development organizations. Perfecting the various in vitro methods and skin-like materials, he interfaced with some of the most innovative R&D teams in the world. In 2019, John aligned himself with Florida Suncare Testing, Inc and sold the IMS technologies to the Bunnell-based clinical and analytical laboratory. An ideal complement to FSTI, IMS operates as a division providing VITRO-SKIN® offerings and advanced pre-clinical testing services.